Terconazole - Patient | NIH - Clinical Info

Skip to main content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

1. Home
2. Drug Database
3. Terconazole

Drug Database: Terconazole

Search Drugs

Drug Database search Apply

Filter by approval status, drug class, and condition

Approval Status: FDA-Approved Investigational Drug Class

• a4ß7 Integrin Antagonist
• Anthelmintics
  • Anthelmintic (Benzimidazole)
• Antibacterials
  • Antibacterials (Aminoglycosides)
  • Antibacterial (Glycopeptide)
  • Antibacterial (Lincosamide)
  • Antibacterial (Macrolide)
  • Antibacterial (Penicillin)
  • Antibacterial (Sulfonamide)
  • Antibacterial (Sulfonamide/Dihydrofolate Reductase Inhibitor)
  • Antibacterial (Sulfone)
  • Antibacterial (Tetracycline)
  • Antibacterial (Quinolone)
• Antifungals
  • Antifungal (Azole)
  • Antifungal (Imidazole)
  • Antifungal (Nucleoside Analog)
  • Antifungal (Polyene)
• Antimalarials
  • Antimalarial (Aminoquinoline)
  • Antimalarial (Dihydrofolate Reductase Inhibitor)
• Antimycobacterials
  • Antimycobacterial (Cyclic Peptide)
  • Antimycobacterial (Rifamycins)
• Antineoplastic
  • Antineoplastic (Anti-CD20 Monoclonal Antibody)
  • Antineoplastic (Anthracycline)
• Antiprotozoal
• Antivirals
  • Antiviral (Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor)
  • Antiviral (Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor)
  • Antiviral (Hepatitis C Virus NS3/4A Protease Inhibitor, NS5A Inhibitor)
  • Antiviral (Hepatitis C Virus NS5A Inhibitor/NS5B Polymerase Inhibitor)
  • Antiviral (Hepatitis C Virus NS5B Polymerase Inhibitor)
  • Antiviral (Hepatitis C Virus NS5B Polymerase Inhibitor, NS5A Inhibitor)
  • Antiviral (Hepatitis C Virus NS5B Polymerase Inhibitor, NS5A Inhibitor, NS3/4A Protease Inhibitor)
  • Antiviral (Hepatitis C Virus [HCV] NS5A Inhibitor, HCV NS3/4A Protease Inhibitor, Cytochrome P450 3A Inhibitor, plus HCV NS5B Polymerase Inhibitor)
  • Antiviral (Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor)
  • Antiviral (Interferon Alpha)
  • Antiviral (Nucleoside Analog)
  • Antiviral (Orthopoxvirus Nucleotide Analog DNA Polymerase Inhibitor)
  • Antiviral (Orthopoxvirus VP37 Envelope Protein Inhibitor)
  • Antiviral (Pyrophosphate Analog DNA Polymerase Inhibitor)
• Attachment Inhibitor
• Broadly Neutralizing Antibodies
• CCR5 Antagonist
• CD4 Attachment Inhibitor
• Capsid Inhibitors
• Combination Drugs
• Fusion Inhibitor
• Gene Therapy Products
• gp120 Attachment Inhibitor
• Immune Globulins
• Immune Modulators
• Integrase Strand Transfer Inhibitor (INSTIs)
  • Integrase Strand Transfer Inhibitor (bictegravir)
  • Integrase Strand Transfer Inhibitor (cabotegravir)
  • Integrase Strand Transfer Inhibitor (dolutegravir)
  • Integrase Strand Transfer Inhibitor (elvitegravir)
• Latency-Reversing Agents
• Maturation Inhibitors
• Microbicides
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitor (doravirine)
  • Non-Nucleoside Reverse Transcriptase Inhibitor (efavirenz)
  • Non-Nucleoside Reverse Transcriptase Inhibitor (rilpivirine)
• Nucleoside Reverse Transcriptase Inhibitor (NRTIs)
  • Nucleoside Reverse Transcriptase Inhibitor (abacavir, lamivudine)
  • Nucleoside Reverse Transcriptase Inhibitor (abacavir, lamivudine, zidovudine)
  • Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir alafenamide)
  • Nucleoside Reverse Transcriptase Inhibitor (emtricitabine, tenofovir DF)
  • Nucleoside Reverse Transcriptase Inhibitor (lamivudine)
  • Nucleoside Reverse Transcriptase Inhibitor (lamivudine, tenofovir DF)
  • Nucleoside Reverse Transcriptase Inhibitor (lamivudine, zidovudine)
• Nucleoside Reverse Transcriptase Translocation Inhibitors
• Pharmacokinetic Enhancers (CYP3A Inhibitors)
  • Pharmacokinetic Enhancer (cobicistat)
  • Pharmacokinetic Enhancer (ritonavir)
• Post-attachment Inhibitor
• Protease Inhibitors (PIs)
  • Protease Inhibitor (atazanavir)
  • Protease Inhibitor (darunavir)
  • Protease Inhibitor (lopinavir)
• Skin and Mucus Membrane Products
  • Skin and Mucus Membrane Products (Immune Response Modifier)
  • Skin and Mucus Membrane Products (Keratolytic Agent)
• Therapeutic Vaccines
• Vaccines
  • Herpes Zoster/Shingles
  • Monkeypox

Condition: Bacterial Enteric Infections Bartonellosis Chagas Disease Coccidioidomycosis Community-Acquired Pneumonia COVID-19 Cryptococcosis Cryptosporidiosis/Microsporidiosis Cystoisosporiasis Cytomegalovirus Disease Disseminated Mycobacterium avium Complex Disease Hepatitis B Virus Infection Hepatitis C Virus Infection Herpes Simplex Virus Disease Herpes Zoster Histoplasmosis Human Herpesvirus-8 Diseases Human Papillomavirus (HPV) Infection Leishmaniasis Malaria Mpox Mucocutaneous Candidiasis Pneumocystis Pneumonia Syphilis Talaromycosis Toxoplasma gondii Encephalitis Tuberculosis Varicella-Zoster Virus Diseases Browse Drug Names A–Z A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # All Apply Patient version Drug information What is terconazole? How is terconazole used in people with HIV? What should I tell my health care provider before using terconazole? How should I use terconazole? What side effects can terconazole cause? How should terconazole be stored? Where can I find more information about terconazole? Prescribing Information FDA label(s) Drug information FDA label information

Print

Patient VersionHTMLFDA Label: Vaginal cream (0.8%) PDFFDA Label: Vaginal suppository PDF

Drug information

Audio drug-audio-en-477.mp3 Download files:

drug-audio-en-477.mp3

Pronounce: Terconazole Drug Class Antifungal (Azole)

What is terconazole?What is terconazole?

What is terconazole?

Terconazole is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of vulvovaginal candidiasis.

Vulvovaginal candidiasis can be an opportunistic infection (OI) of HIV. An OI is an infection that occurs more frequently or is more severe in people with weakened immune systems—such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the HIVinfo What is an Opportunistic Infection? fact sheet.

How is terconazole used in people with HIV?How is terconazole used in people with HIV?

How is terconazole used in people with HIV?

The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV include recommendations on the use of terconazole in people with HIV to treat uncomplicated vulvovaginal candidiasis and severe or recurrent episodes of vulvovaginal candidiasis.

The recommended uses may not always be consistent with FDA-approved uses of terconazole. See the Guidelines for complete information on recommended uses of terconazole in adults and adolescents with HIV. Terconazole may have other recommended uses not listed above.

What should I tell my health care provider before using terconazole?What should I tell my health care provider before using terconazole?

What should I tell my health care provider before using terconazole?

Before using terconazole, tell your health care provider:

• If you are allergic to terconazole or any other medicines.
• About any medical conditions you have or have had, such as diabetes.
• About anything that could affect your ability to use terconazole, such as difficulty with inserting a vaginal suppository or applying a cream to the affected area or trouble remembering a scheduled dose.
• If you are pregnant or plan to become pregnant. Terconazole should not be used in the first trimester of pregnancy unless it is essential for your health. Terconazole may be used during the second and third trimester if the potential benefit outweighs the possible risks to the fetus. Talk to your health care provider about the risks and benefits of using terconazole during pregnancy. The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV may include other recommendations on the use of terconazole during pregnancy. Please refer to these guidelines for additional information.
• If you are breastfeeding or plan to breastfeed. For mothers with HIV in the United States, the Guideline recommends speaking with your health care provider to discuss options for feeding your baby. Mothers with suppressed viral load have a less than 1% chance of transmitting HIV to their baby via their own milk. Although most medicines are safe to use while breastfeeding, some medicines should be avoided. Always let your health care provider know about all the medicines and supplements you are using before you start breastfeeding.
• About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Terconazole may affect the way other medicines or products work, and other medicines or products may affect how terconazole works. Ask your health care provider if there are interactions between terconazole and the other medicines you take.

How should I use terconazole?How should I use terconazole?

How should I use terconazole?

Use terconazole according to your health care provider’s instructions. Your health care provider will tell you how much terconazole to use and when to use it. Before you start terconazole and each time you get a refill, read any printed information that comes with your medicine.

What side effects can terconazole cause?What side effects can terconazole cause?

What side effects can terconazole cause?

Terconazole may cause side effects that can be mild or serious. To learn about possible side effects of terconazole, see the FDA drug labels for terconazole vaginal suppository and vaginal cream (0.8%) or talk to your health care provider or pharmacist. Tell your health care professional if you have any side effect that bothers you or that does not go away. Your health care professional may be able to tell you about ways to prevent or reduce some side effects.

You may report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088) or online.

How should terconazole be stored?How should terconazole be stored?

How should terconazole be stored?

• Store terconazole vaginal cream (0.8%) and vaginal suppositories at room temperature, 68°F to 77°F (20°C to 25°C).
• Do not use terconazole if the original seal over the container opening is broken or missing.
• Throw away terconazole that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
• Keep terconazole and all medicines out of reach of children.

Where can I find more information about terconazole?Where can I find more information about terconazole?

Where can I find more information about terconazole?

• Recommendations on the HIV-related use of terconazole, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.
• This Patient Version drug summary is based on the following FDA label(s): Vaginal suppository; Vaginal cream (0.8%). The Patient Instructions include information for people using terconazole.
• The American Hospital Formulary Service (AHFS) Patient Medication Information for terconazole vaginal cream, vaginal suppositories available from MedlinePlus.
• Terconazole-related research studies, from ClinicalTrials.gov. (The ClinicalTrials.gov search can be modified so that you can get results that better match your interests.)

Last Reviewed: January 28, 2025

home message

Print

Patient VersionHTMLFDA Label: Vaginal cream (0.8%) PDFFDA Label: Vaginal suppository PDF